서울 최준호는 다음과 같은 동명이인이 있다.* [[자연과학대학최준호(생명과학과)]] 는 [[생명과학과한양대학교]] 교수이다. = 학력 =* 2003.04 - 2007.02, The University of Sydney, Majored in Biochemistry, Bachelor of Science* 2007.03 - 2009.02, 고려대학교 생명고학과, 분자세포생물학전공, 이학석사* 2009.03 - 2013.02, 고려대학교 생명공학과, 분자생물학전공, 이학박사 = 경력 =* 2013.03 - 2013.10, 고려대학교 생명과학과, 박사후 연구원 [[최준호(Advisor: Yoon Ki Kim정신건강의학과)* 2013.11 - 2014.05, 고려대학교 생명과학과, 연구교수 (Advisor: Yoon Ki Kim)* 2014.07 - 2019.01, Boston Children’s Hospital / Harvard Medical School, Postdoctoral Fellow (Advisor: Richard I. Gregory) = 연구관심분야 =* RNA 후성유전체학 (Epitranscriptomics)* RNA modification을 통한 mRNA 안정성 조절 및 단백질 발현 조절 연구* RNA modification을 통한 종양형성 (Tumorigenesis) 연구* 배아줄기세포 (Mouse Embryonic Stem Cell) 에서의 유전자 발현 조절 연구 = 주요논문 =# mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis. Nature, 561(7724):556-560, 2018# The m6A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. Mol cell, 62(3):335-45, 2016# eIF4AIII enhances translation of nuclear cap-binding complex-bound mRNAs by promoting disruption of secondary structures in 5'UTR. Proc Natl Acad Sci U S A, 111(43):E4577-86, 2014# The mRNP remodeling mediated by UPF1 promotes rapid degradation of replication-dependent histone mRNA. Nucleic Acids Research, 42(14): 9334-49, 2014# Rapid degradation of replication-dependent histone mRNAs largely occurs on mRNAs bound by nuclear cap-binding proteins 80 and 20. Nucleic Acids Research, 41(2):1307-18, 2013 = 수상 =* 2013, Excellent Research Award by Korea University* 2012, Excellent Research Award by Korea University* 2011, Excellent Research Award by Korea University* 2011, Excellent Poster Award by KSCB* 2010, Excellent Research Award by KSMCB - The RNA Society of Korea* 2010, Excellent Poster Award by KSCB* 2009, Fellowship from Seoul* 2007, Fellowship from KRF (Korea Research Foundation) ]]는 [[분류:교수한양대학교]][[분류:생명과학과구리병원]][[분류:동명이인정신건강의학과]]교수이다.